Lymphatic filariasis elimination: progress in global programme development.
Molyneux
D H
DH
Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, UK. fahy@liv.ac.uk
Zagaria
N
N
D015766:Albendazole / Q000627:therapeutic use; D003906:Developing Countries; D004185:Disability Evaluation; D004605:Elephantiasis, Filarial / Q000453:epidemiology / Q000517:prevention & control*; D005369:Filaricides / Q000627:therapeutic use; D005381:Financing, Organized; D006296:Health Services / Q000592:standards; D006801:Humans; D007391:International Cooperation; D007559:Ivermectin / Q000627:therapeutic use; D009938:Organizations / Q000458:organization & administration; D016730:Program Development / Q000191:economics / Q000379:methods*; D014944:World Health Organization
D005369:Filaricides; D007559:Ivermectin; D015766:Albendazole